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Abstract 
Background: In the absence of a true lymphatic system in the brain parenchyma, alternative clearance pathways for 
excess fluid and waste products have been proposed. Suggested mechanisms for clearance implicate a role for brain 
interstitial and cerebrospinal fluids. However, the proposed direction of flow, the anatomical structures involved, and 
the driving forces are controversial.
Methods: To trace the distribution of interstitial and cerebrospinal fluid in the brain, and to identify the anatomical 
structures involved, we infused a mix of fluorescent tracers with different sizes into the cisterna magna or striatum of 
mouse brains. We subsequently performed confocal fluorescence imaging of horizontal brain sections and made 3D 
reconstructions of the mouse brain and vasculature.
Results: We observed a distribution pattern of tracers from the parenchyma to the ventricular system, from where 
tracers mixed with the cerebrospinal fluid, reached the subarachnoid space, and left the brain via the cribriform plate 
and the nose. Tracers also entered paravascular spaces around arteries both after injection in the cisterna magna and 
striatum, but this appeared to be of minor importance.
Conclusion: These data suggest a bulk flow of interstitial fluid from the striatum towards the adjacent lateral ventri‑
cle. Tracers may enter arterial paravascular spaces from two sides, both through bulk flow from the parenchyma and 
through mixing of CSF in the subarachnoid space. Disturbances in this transport pathway could influence the drain‑
age of amyloid β and other waste products, which may be relevant for the pathophysiology of Alzheimer’s disease.
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Background
Brain function is critically dependent on the extracel-
lular fluids that surround the neurons. Interstitial fluid 
(ISF) is in direct contact with neuronal cells and delivers 
nutrients and oxygen, while at the same time it removes 
waste products. Brain ISF is derived from water and sol-
utes that enter through the blood–brain barrier. This 
process allows specific ion transporters and channels 
to regulate its composition [1]. Next to ISF and blood 
plasma, cerebrospinal fluid (CSF) forms the third extra-
cellular fluid compartment of the brain. The composi-
tion of CSF differs minimally from ISF, which suggests 
a relatively free communication between CSF and ISF. 
Although recent work identified lymphatic vessels in the 
dura mater [2, 3], the brain parenchyma lacks a true lym-
phatic system. CSF may take over this role in fluid bal-
ance and waste removal, by drainage of excess fluid from 
arachnoid granulations, the aforementioned dural lym-
phatics, and other pathways. The classical view is that 
CSF is mainly secreted by specialized vascular structures, 
the choroid plexuses [4]. The CSF subsequently flows 
through the ventricular system of the brain, which con-




*Correspondence:  b.bedussi@amc.uva.nl; n.t.bakker@amc.uva.nl 
Department of Biomedical Engineering and Physics, Academic Medical 
Center, Room L0‑119. Meibergdreef 9, PO Box: 22660,  
1105 AZ Amsterdam, The Netherlands
Page 2 of 13Bedussi et al. Fluids Barriers CNS  (2015) 12:23 
the fourth ventricle, which finally connects to the suba-
rachnoid space. However, recent insights suggest that 
CSF and ISF physiology is much more complex than pre-
viously believed [5, 6]. Thus, CSF and ISF may exchange 
over the ependymal epithelium that covers the ventricu-
lar system [7, 8], and CSF may also reenter the paren-
chyma along paravascular pathways [4, 6, 9]. In addition, 
ISF may drain along basement membranes of capillaries 
and arteries, retrograde to the direction of blood flow 
[10]. Understanding the drainage pathways of the brain is 
required for unraveling the removal mechanisms of toxic 
waste products such as amyloid β, as well as for develop-
ing targeted delivery of treatment modalities. Therefore, 
the current study set out to investigate clearance from 
the brain. In particular, we focused on paravascular path-
ways as a clearance mechanism. To this extent we infused 
tracers in the ISF (striatum) and CSF compartment (cis-
terna magna, CM) and studied their distribution by con-
focal imaging of brain sections and 3D reconstruction of 
the whole mouse head using an imaging cryomicrotome.
Methods
Animals
For this study, 20 animals were included, 10 for injection 
in the striatum (7 for confocal microscopy, 3 for 3D cry-
omicrotome imaging) and 10 for injection of tracers in the 
cisterna magna (5 for confocal microscopy, 5 for 3D cry-
omicrotome imaging). Male C57BL/6JOlaHsd mice were 
obtained from Harlan (The Netherlands). Animals were fed 
ad  libitum with standard laboratory food and free access 
to water. They were allowed to acclimatize for at least 
1 week before being enrolled in experimental protocols. All 
experimental protocols were approved by the Committee 
for Animal Experiments of the Academic Medical Center 
Amsterdam, according to the EU guidelines.
Anesthesia
In all experiments mice were anesthetized with a mixture 
of ketamine (126  mg/kg, Nimatek, Eurovet, Bladel, The 
Netherlands) medetomidine (0.2 mg/kg, Dormitor, Orion 
Pharma, Mechelen, Belgium) and atropine (0.5  mg/kg, 
Atropinesulfaat, Eurovet) in PBS (Phosphate Buffered 
Saline, Lonza, Basel, Switzerland) by intraperitoneal 
injection (75 μl/10  g body weight). To prevent swelling 
of the brain, 0,2  mg/ml dexamethason (Sigma-Aldrich, 
Zwijndrecht Nederland) in 20 % ethanol (10 μl/10 g body 
weight) was added to the anesthetic mixture. Experi-
ments were carried during daytime hours, i.e. in the 
sleeping phase of the mouse diurnal rhythm.
Reagents
Dextran, Texas Red-labeled (3 kD, Ex. 595  nm/Em. 
615  nm) and dextran, Fluorescein-labeled (500 kD, Ex. 
494  nm/Em. 521), both lysine-fixable, were purchased 
from Molecular Probes-Life Technologies (Eugene, OR, 
USA). For immunofluorescence, brains were embed-
ded in Tissue-Tek (Sakura, Leiden, The Netherlands) 
before freezing and sectioning. Cell nuclei were stained 
with VECTASHIELD Mounting Medium with DAPI (4, 
6-diamidino-2-phenylindole, Burlingame, CA, USA) 
according to the manufacturer’s protocol. Anti-Laminin 
antibody (Sigma-Aldrich) was used to visualize the 
vasculature.
Experimental procedure
When the animals were completely anesthetized, their 
heads were shaved. Next, the animals were fixed in a ste-
reotactic frame (lab standard stereotaxic, Stoelting, Dub-
lin, Ireland), while the head was kept at the same level as 
the body. To maintain physiological body temperature, 
animals were placed on a heating pad. Additional oxy-
gen (99  %) was provided to prevent hypoxia and ocular 
lubricant ophthalmic (DURATEARS, Alcon, Breda, The 
Netherlands) was used to keep the eyes hydrated. In this 
study we used two different injection sites: the cisterna 
magna and the striatum. For cisterna magna injections, 
after separating the subcutaneous tissues and the midline 
of the neck muscle, a 29-gauge needle was placed into 
the cistern and connected to a polyethylene catheter. A 
total volume of 5 μl of a mixture (1:1) of both dextrans, 
3 kD Texas Red (10 g/l), and 500 kD dextran, Fluorescein 
(10 g/l), was infused at a controlled flow rate of 0.17 μl/
min using a syringe pump (Harvard Apparatus, Hollis-
ton, MA, USA) over a 30 min period. For injection into 
the striatum (coordinates from the Bregma 0.5 mm ros-
tral, 1.5  mm lateral, and 2.5  mm deep), animals were 
completely anesthetized, the skull was exposed and after 
additional local anesthesia (Xylocaine 10 %, AstraZeneca 
BV, Zoetermeer, The Netherlands), a small burr hole was 
drilled using a dental drill. Subsequently, a custom-made 
33-gauge polyethylene catheter was inserted into the 
brain using the stereotactic device. For this site of injec-
tion we anticipated that the maximum volume tolerated 
is smaller than in the cisterna magna. For this reason, 
2 μl of the dextran mixture was infused at a controlled 
flow rate of 0.066 μl/min, over a 30 min period. In both 
protocols, animals were euthanized with an overdose 
of anesthetic 30 min after start of the infusion. Needles 
were removed after death.
Confocal microscopy
After sacrifice of the animal the brains were dissected, 
embedded in Tissue-Tek and frozen in liquid nitrogen 
prior to storage at −80  °C. Samples were cut longitudi-
nally with a microtome (5 μm slices). We used 3.7 % par-
aformaldehyde to fix the slices and mounted them with 
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Vectashield mounting medium containing DAPI nuclear 
stain. Images were acquired using a Confocal Laser Scan-
ning Microscope (Leica TCS SP8, Buffalo Grove, IL, 
USA). A 10× oil immersion was used for the overviews 
and a 20× oil immersion objective was used to image the 
details.
3D cryomicrotome imaging
After surgery, animals were flushed with PBS to remove 
the blood in the vasculature prior to vascular filling with 
the replica material via the abdominal aorta. To fill the 
vasculature we used fluorescent (UV blue, excitation 
375 nm, emission 505 nm, VasQtec, Zurich, Switzerland) 
replica material (Batson’s #17, Polysciences, Eppelheim, 
Germany). After filling and polymerization, the speci-
mens were frozen at −20 °C for at least 24 h and then the 
heads were cut with a guillotine. The frozen specimens 
were embedded in a black gel (carboxymethylcellulose 
sodium solvent 5  %—Brunschwig Chemie, Amsterdam, 
The Netherlands– mixed with Indian ink 5 %—Royal Tal-
ens, Apeldoorn, The Netherlands), and placed at −20 °C. 
Each sample was cut from nose to the second cervical 
vertebrae using 50 μm slice thickness for the nose until 
the start of the brain and 10 μm for the remaining part 
of the head, using an imaging cryomicrotome (custom 
made, Amsterdam, The Netherlands) [11, 12]. After each 
slice a white light picture of the sample and episcopic 
fluorescent images for the Dextrans, 5 kD Texas Red 
(exitation 577  nm, emission 635  nm), and 500 kD Dex-
tran, Fluorescein (exitation 480  nm, emission 535  nm) 
and vascular cast were recorded (excitation 365  nm, 
emission 505 nm) using a 4096 × 4096, 16 bit resolution 
digital camera (Apogee Alta U-16, Oceanside, CA, USA) 
equipped with a variable- focus lens (Nikon 70–180 mm, 
Amsterdam, The Netherlands). The resulting registered 
stack of sequential images contained on average 2200 
images per color with an in-plane resolution of 5 μm.
Image processing
For visualizing purposes, two adjacent slices were com-
bined using maximal intensity projection and converted 
to 8 bit greyscale images. The head was reconstructed 
in 3D using Amira (Visage Imaging GmbH, Berlin, Ger-
many). This yielded a detailed 3D virtual representation 
of the mouse head vasculature with co-localized dextran 
deposition.
Results
Tracers move from the striatum into the ventricles via ISF
To investigate clearance pathways in the brain inter-
stitium, we infused a mixture of a low molecular weight 
tracer, TR-3, and a high molecular weight tracer, F-500, 
in the striatum of mice (n = 7). We used this combina-
tion of high and low molecular weight tracers to esti-
mate the respective contributions of diffusion and bulk 
flow to dispersion, as there should be a ~fourfold differ-
ence in diffusion distance of these tracers based on their 
diffusion coefficients in the brain [13]. We analyzed the 
distribution of the tracers by confocal fluorescence imag-
ing of horizontal brain sections. This showed that the 
tracers had spread from the infusion site through the 
parenchyma towards the closest lateral ventricle (Fig. 1). 
The co-localization of the dyes, the directionality of this 
transport and the distance traveled indicate that this 
transport is dominated by convection. F-500 followed 
intercellular spaces from the site of injection to the wall 
of the ventricle. There, it crossed the ependymal layer and 
was detected in the ventricular cavity. TR-3 followed the 
same route, but was also taken up by parenchymal cells 
along the way towards the ventricle. Both tracers were 
detected further along the ventricular system, reaching 
the 3rd and 4th ventricle. In some experiments the trac-
ers had reached the downstream subarachnoid space. 
Detailed images show the presence of both tracers in the 
lateral ventricle (B), cisterns (C), and the subarachnoid 
space (SAS; D). Figure 1e shows that TR-3 entered paren-
chymal cells, while F-500 appeared to remain confined to 
the extracellular spaces.
The low molecular weight tracer penetrates the choroid 
plexus
After infusion in the striatum, we observed that both 
tracers crossed the ependymal cells into the ventricle. 
However, particularly F-500 accumulated in the paren-
chyma close to the ependyma, suggesting it acts as a par-
tial barrier for this tracer (Fig. 2a–d). Such accumulation, 
in the course from the injection site to the ventricle, is a 
strong additional indication for bulk flow from the paren-
chyma of the striatum. We also observed a bright signal 
for TR-3 in the choroid plexuses. TR-3 clearly penetrated 
the epithelial cells of the choroid plexus while F-500 was 
confined to extracellular side of the same cells (Fig. 2e–h).
3D reconstruction of blood vessels and tracer 
transport in the mouse’s head after infusion in the 
striatum
3D images of tracer distribution after injection in the 
striatum were generated by an imaging cryomicrotome. 
After sacrifice of the animal, blood vessels were filled 
with fluorescent cast material via the aorta, in order to 
map tracer distribution against the vasculature. The 
whole mouse head was sectioned (approximately 2500 
sections) after freezing. En face fluorescent images 
were taken during automated sectioning. This approach 
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preserves dye present in fluid compartments (ISF and 
CSF), which could be lost during sectioning and process-
ing. In addition, since we included the whole mouse head, 
it also captured the drainage pathways from the brain to 
peripheral structures. Figure 3 shows tracer distribution 
after 30  min continuous infusion in the striatum. Simi-
lar to the confocal images, in the 3D reconstruction we 
observed that tracers drained from the striatum to the 
adjacent lateral ventricle. 2D coronal views of the brain 
(Fig. 3c–e) show the presence of F-500 further along the 
external capsule, in the ventral side of the olfactory bulb, 
the nasal turbinates, as well as the contralateral ventricle 
and third ventricle (Additional file  1). Similar to F-500, 
TR-3 was observed in the parenchyma close to the injec-
tion site, from where it followed the same route towards 
the ventricular system (not shown). Thus, these images 
confirmed the observations made with confocal imaging 
on tracer clearance from the parenchyma by bulk flow of 
ISF towards the ventricles.
Tracers injected into the cisterna magna disperse over the 
subarachnoid space
We next evaluated bulk flow using tracer infusion in 
the cisterna magna, using the same mix of tracers as 
injected into the striatum (n  =  5). Again we used a 
30  min continuous infusion, to map the distribution 
of tracers from their injection site. Confocal imaging 
showed that after 30 min of infusion, both tracers dis-
tributed over the subarachnoid space and entered the 
large cisterns of the brain. As shown in the overview 
(Fig. 4a) and in detail in panel b, the ventricles showed 
no signal, indicating that the tracers did not enter the 
ventricular system, neither along the CSF pathways 
nor via transport through the cortex, interstitial com-
partments and ventricular ependyma. Other views 
(Fig. 4c, d) showed that F-500 remained confined to the 
subarachnoid space, whereas TR-3 also penetrated the 
parenchyma, crossing the pia mater. This is particularly 
evident close to the tentorium cerebelli, and around 
Fig. 1 Distribution of the tracers (TR‑3 and F‑500) 30 min after injection in the striatum. a Tile scan of a horizontal brain section at −2 mm from the 
bregma. A distinct distribution of the tracers towards the lateral ventricle was observed. Scale bar 1 mm. Anatomical details are shown in panels B–E. 
b Ventricle and choroid plexus. Tracers coming from the parenchyma reached the ventricle, crossing the ependymal layer. TR‑3 is taken up by the 
choroid plexus while F‑500 stays on its outer layer. Scale bar 100 µm. c The ambient cistern showed both tracers. Scale bar 100 µm. d The subarach‑
noid space showed both F‑500 and TR‑3, although the signal of TR‑3 is weaker compared to F‑500. Note the autofluorescence of elastin (red) in the 
meningeal artery. Scale bar 100 µm. Panel e Detail of the brain parenchyma. TR‑3 is observed intra‑ and intercellular, while F‑500 appears to remain 
extracellular. Scale bar 10 µm
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the olfactory bulb. Analysis of TR-3 penetration across 
the pial layer indicated that this tracer was detected up 
to ~200 µm into the cortex (Fig. 4e). The average pen-
etration depth was 64 µm.
Reconstruction of the mouse head in 3D after tracer 
infusion in the cisterna magna
We next studied 3D tracer distribution after injection 
of tracers in the cisterna magna. Figure  5a, b show the 
vasculature (in blue) and the tracers (F-500 in green 
and TR-3 in red); Fig. 5c–e show coronal views. The 3D 
image confirmed the observations made with confo-
cal imaging (Additional file 2). Thus, most of the tracers 
were confined to the subarachnoid space, with a stronger 
signal for both tracers on the ventral side of the brain 
(Fig. 5e). Additionally, the dye was found in the longitudi-
nal fissure, and around the major vessels arising from the 
cortex and ventral side of the brain (Fig. 5c–e). Interest-
ingly, outside the brain the strongest signal for both was 
observed in the nose (Fig. 5c). The continuous presence 
of both dyes between the olfactory bulb and the nose 
suggest that these tracers leave the brain through the cri-
briform plate (Fig. 5c). The ventricular system was com-
pletely devoid of tracers (Fig. 5d). TR-3 showed the same 
distribution pattern, but more diffuse and less intense 
(not shown).
Role of blood vessels in clearance
To further analyze the involvement of the vasculature and 
its peri- and/or paravascular spaces as potential distribu-
tion pathways, we stained sections with an anti-laminin 
antibody. Laminin-positive staining was observed both 
within the walls of blood vessels (arteries, veins, capillar-
ies) and the meninges. Among blood vessels, large arter-
ies could easily be discriminated from veins, particularly 
in the SAS, based on the autofluorescence of elastin 
(Fig.  6a). Following injection into the cisterna magna 
(CM), tracers were seen around both arteries and veins 
in the SAS, with penetration of dye along the vessel walls 
of arteries into the parenchyma (Fig.  6a). There was no 
visible boundary or difference in signal intensity between 
the paravascular signal and the subarachnoid space, sug-
gesting that the subarachnoidal and paravascular spaces 
form a continuous fluid compartment (Fig.  6a). Tracers 
were most clearly visible in the ambient cistern where 
also several large arteries enter the brain (Fig. 6b). Note 
that TR-3 penetrated the parenchyma of the cerebrum 
but not the cerebellum. Within the parenchyma of the 
cerebrum, F-500 was observed along vessels that pen-
etrate the brain from the ventral side (Figs. 6c, 7). Based 
on wall thickness, these vessels were most likely arter-
ies. Following injection into the striatum, neither capil-
laries, nor veins close to the injection site in the striatum 
Fig. 2 Penetration of TR‑3 in the choroid plexus after striatum injection. Horizontal section −3 mm from the bregma. a–d Overview of the lateral 
ventricle. F‑500 accumulated towards the ependymal layer (a) while TR‑3 appeared to cross the ependymal more easily (b). Cell nuclei stained with 
DAPI (c). A merged picture is shown in panel d. e–g Detail of the choroid plexus. F‑500 remains confined to the surface of the choroid plexus (e) 
while TR‑3 clearly penetrated the choroid plexus (f). Cell nuclei stained with DAPI (g). Merged picture (h). Scale bar 100 µm
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Fig. 3 Three dimensional reconstruction of the vasculature and distribution of tracers in a mouse head after injection in the striatum. a F‑500 is 
present at the injection site, the lateral ventricles and in the olfactory bulb. b TR‑3 is present in the same compartments but could not be detected 
in the olfactory bulb. Panels C–E represent maximum intensity projections of 50 images at the indicated levels shown in a of the vasculature and 
F‑500. c F‑500 reached the nasal turbinates through the cribriform plate. d F‑500 distributed in the striatum, reached the external capsule (EC), and 
the contralateral ventricle (LV) via the ventricular system. e The aqueduct of sylvius showed F‑500. Panels a, b: dorsal view. Panels c–e: coronal view. 
Scale bar 1 mm
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Fig. 5 Three dimensional reconstruction of the vasculature with co‑localized distribution of tracers in a mouse head after injection in the cisterna 
magna. a F‑500 was found in the subarachnoid space and along the penetrating arteries of the brain. b TR‑3 was observed in the same compart‑
ment, but less confined and also diffusely present in the brain parenchyma. This was particularly evident around the large arteries of the circle of 
Willis. c Outside the brain, a strong signal was found in the nasal turbinates and along the optic nerves. Maximum intensity projections of 50 images 
at the indicated levels of the vasculature and F‑500 are shown in panels C–E. Panels a, b: dorsal view; c–e: coronal view. Scale bar 1 mm
(See figure on previous page.) 
Fig. 4 Distribution of the tracers 30 min after injection in the cisterna magna. a Tile scan of a horizontal section −2 mm from the bregma. The 
ventricular system showed no signal, while the olfactory bulb and the subarachnoid space showed both tracers. TR‑3 and F‑500 were observed in 
the subarachnoid space along the entire section. Scale bar 1 mm. Anatomical details are shown in panels B–D. b The ventricle and choroid plexus did 
not show TR‑3 and F‑500. c The ambient cistern showed both tracers, with TR‑3 also entering the adjacent parenchyma. d A leptomeningeal vein (v, 
arrow) in the SAS showed F‑500 in the paravascular space. Scale bar 100 µm. e Signal intensity as a function of distance for TR‑3 from the SAS to the 
brain parenchyma across the pial layer, 30 min after CM injection. The mean distance is 64 ± 7 µm (N = 5)
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(Fig. 6d), nor the parenchymal vessels close to the lateral 
ventricle (Fig. 6e) showed tracers. However, occasionally 
tracers were seen to accumulate towards arteries ventral 
to the injection site and along the vessel walls near the 
cortex (Fig. 6f ). In this case, TR-3 was seen along the ves-
sel walls, while F-500 accumulated towards the pia mater. 
These observations suggest bulk flow of ISF close to the 
surface of the cortex towards the SAS.
Discussion
In this study we investigated clearance from the brain 
and the role of peri- and paravascular pathways herein. 
The perivascular route is considered to be located along 
basement membranes within the vessel wall [10]. On the 
other hand, the paravascular space is located in between 
the brain parenchyma (astrocyte endfeet) and the vessel, 
and is filled with CSF [9]. The contribution of diffusion 
and bulk flow in the removal of metabolites and waste 
from brain extracellular fluids is a longstanding debate 
that recently has regained interest. Based on earlier work 
from Cserr [14–16], Rennels [4], Weller [10], and oth-
ers, Abbott [6] concluded that ISF is not a static fluid, 
although a later review by Sykova and Nicholso [13] con-
cludes that bulk flow is likely to be restricted to perivas-
cular spaces and the main mechanism for exchange in the 
brain extracellular space is diffusion. More recent work of 
the Nedergaard group [9, 17, 18] suggests that paravascu-
lar pathways provide an influx route for CSF along arter-
ies, which mixes with ISF and leaves the brain via venous 
outflow pathways. However, as pointed out by Hladky 
and Barrand [19], this view is at variance with many ear-
lier studies and awaits further confirmation.
Bulk flow from the striatum towards the ventricular system
The current study presents several arguments for the 
presence of bulk flow of interstitial fluid from the stria-
tum towards the ventricles. The first evidence is the 
transport of the tracers after injection into the striatum, 
Fig. 6 Role of the vasculature in bulk flow. a–c Cisterna magna injection, d–f striatum injection. Additional laminin staining is present in panels 
b–f. a Tracers were found in the subarachnoid space, embedding arteries (a) and veins (v). Arteries showed additional red autofluorescence from 
elastin. Green arrows F‑500 followed paravascular spaces along arteries into the parenchyma. b F‑500 was prominent in cisterns, where large arteries 
entered the brain (green arrow). c F‑500 entered the paravascular space of vessels from the ventral side of the brain (green arrows). d Small vessels 
close to the injection site did not show tracers. e Choroid plexus with TR‑3 and F‑500, adjacent veins (v) did not show tracers. f Both tracers followed 
blood vessels towards the brain surface. F‑500 accumulated at the pia mater. Scale bar 100 µm
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where the tracers distribute from the injection towards 
the nearest lateral ventricle. Both F-500 and TR-3 moved 
along extracellular spaces, albeit that TR-3 was also taken 
up by parenchymal cells, in accordance with in vitro data 
[20]. Such transport could theoretically be caused by 
diffusion, convection, or both. Discrimination between 
these processes is possible based on the distances trave-
led and the directionality of such transport. F-500 would 
be expected to diffuse a far smaller distance than TR-3 
which, in our hands, was not the case. In addition, F-500 
clearly moved towards the ventricles, and accumulated 
strongly at the ependymal layer. The accumulation is sug-
gestive of a sieving process, where ISF is transported to 
the ventricle and part of the tracer stays behind. For the 
small TR-3, transport distances for diffusion would still 
be in the order of magnitude that we found [13], but also 
here the tracer preferentially moved towards the ventri-
cles. This dye accumulated to a lesser extent, reflecting 
the possibility that it passes the ependymal layer more 
easily than F-500. Taken together, this suggests a sig-
nificant contribution of tracer drainage by ISF bulk flow 
from the striatum into the ventricular system. In the 
lateral ventricle, ISF mixes with CSF once it passes the 
ependymal cells at the ventricle edge. Then, tracers fol-
low CSF bulk flow along the ventricular system and get 
further distributed over the subarachnoid space.
The choroid plexus as a potential exit route from the CSF
Floating in the ventricles, the choroid plexus is consid-
ered as the main source of CSF. In this study, we found 
that TR-3 penetrates into the choroid plexus. Distances 
are short, so penetration could be the result of diffusion 
from the ventricular CSF. Alternatively, it has been shown 
that active transport can be bi-directional over the epi-
thelial cells of the choroid plexus [21]. The epithelial cells 
of the choroid plexus constitute the blood-CSF barrier 
(BCSFB) that limits the movement of solutes from blood 
to the CSF and vice versa. However, like the blood–brain 
barrier, the BCSFB contains transport systems for influx 
and/or efflux of nutrients, metabolic products and ions, 
and might also be involved in detoxification processes 
[21, 22]. This also opens the possibility that the choroid 
plexus may function as an exit route for waste products 
from the CSF. Indeed, ex vivo data show the removal of 
amyloid β from the choroid plexus [23] and in vivo, there 
is a correlation between choroid plexus dysfunction and 
amyloid β removal [24]. Nevertheless, the current data 
did not allow us to discriminate between diffusion and 
active transport of this particular tracer over the BCSFB.
Lack of evidence for bulk flow from the subarachnoid 
space and paravascular spaces into the brain parenchyma
CSF and ISF may not only communicate at the ependy-
mal layer of the ventricles, but also at the pial level [16]. 
In our experiments, after injection into the cisterna 
magna, the mixture of fluorescent tracers spread in the 
subarachnoid space. We observed that TR-3 entered the 
parenchyma close to the SAS and arteries, while F-500 
was confined to the SAS and paravascular spaces. The 
TR-3 signal decreased steeply in deeper cortex layers, 
and was detected up to about 0.2 mm deep. Based on the 
diffusion coefficient for TR-3 in brain tissue [25], and an 
Fig. 7 Different appearance of tracers around parenchymal vessels according to the injection site. a A case where tracers accumulated around an 
artery (A), after injection in the striatum. TR3 was taken up by smooth muscle ce6lls and parenchymal cells, whereas F500 was not. b Two paren‑
chymal vessels showing F500 after injection in the cisterna magna. In this case the tracer entered the paravascular space from the CSF, but did not 
enter the parenchyma. We speculate that in panel a tracers were carried by bulk flow towards the artery, whereas in panel b the tracer entered the 
paravascular space as a result of the continuity with the SAS and the strong mixing action caused by pulsations in the CSF. Scale bar 50 µm
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average diffusion time of 15 min in our experiments, one 
would estimate that this tracer may diffuse over an aver-
age distance of ~0.31 mm. This is more than the average 
distance that we observed:  ~0.064  mm. Therefore, the 
penetration of tracer appears to be less than can be antic-
ipated on the basis of diffusion. In fact, the small penetra-
tion depth suggests that diffusion is possibly hindered 
by bulk flow in the opposite direction. Thus, we suggest 
that in the current settings, there was limited penetration 
of small solutes from the SAS into the brain by diffusion 
(Fig. 4), and no bulk flow from the SAS and paravascu-
lar spaces into the brain parenchyma. This is further 
substantiated by the distribution of the high molecular 
tracer along the paravascular spaces. Thus, F-500 showed 
a steep decrease in intensity along arteries entering the 
brain, while a constant or even an increased concentra-
tion of dye would be expected due to a sieving action 
with paravascular inflow of CSF. A more likely explana-
tion for the distribution of tracers over the SAS and along 
paravascular spaces could therefore be the strong mixing 
movement in the subarachnoid space due to arterial pul-
sations [26].
Bulk flow of ISF: a continental divide
The current study suggests the presence of bulk flow of 
ISF from the striatum toward the ventricular system. We 
found no evidence for a contribution of recirculation or 
re-entrance from the sub-arachnoid or para-vascular 
spaces to this ISF flow. At this point, our interpretation 
differs from the glymphatic concept [9]. In particular, we 
did not observe outflow along parenchymal veins towards 
the subarachnoid space. Leptomeningeal veins may have 
shown tracers simply because the tracers are present in 
the SAS. Rather, the picture that emerges from our data 
is that ISF flow is generated by the transport of fluid from 
the capillaries to the interstitium. In other organs, such 
fluid transport is believed to be a very local phenom-
enon. According to the Starling balance of hydrostatic 
and oncotic pressures, fluid leaves higher pressure cap-
illaries, close to the arterioles, and is mostly reabsorbed 
by venous capillaries. The remainder is removed by the 
lymphatic system. In the brain, fluid transport from cap-
illaries to interstitium depends on active transport of ions 
and solutes rather than Starling forces, and reabsorption 
is thought to be absent [19]. Such fluid therefore needs 
to find its way to the CSF compartment. This would gen-
erate a cumulating flow, small in regions far from the 
ventricles (like rivulets high up in the mountains), and 
much larger when approaching the ventricles. Occasion-
ally (Fig. 6f ) we observed that tracer present close to the 
cortical surface finds its way to the brain surface along 
blood vessels. These findings resemble the observations 
by Weller [10]. We therefore speculate that there is a 
‘continental divide’, a point of highest interstitial pressure 
where generated ISF flows to either the ventricles or the 
cortex. We suggest that in the mouse this watershed is 
situated very close to the cortical surface. Indeed, Arbel-
Ornath [27] found that when tracers are injected in the 
cortex, they quickly drain out of the brain along arteries. 
In this analogy, peri- and paravascular spaces could be 
seen as fjords, allowing fluid transport from the moun-
tains to the sea. It should be mentioned that the con-
cept of fluid generation from capillaries is controversial 
[28–31], and we see the above view as a working hypoth-
esis. Many issues remain to be addressed, including the 
nature and regulation of water transport over the BBB, 
the amount of generated ISF/CSF volume as compared 
to production by the choroid plexus, the interstitial pres-
sure profile, relevance for removal of toxic products, and 
relevance for other species and conditions, notably for 
humans.
Limitations
Injection of bulk fluid may be a confounding factor 
when studying interstitial fluid transport. The contribu-
tion of the infusion rate to tracer distribution is difficult 
to establish. We used an infusion rate far less than many 
theoretical [32] and experimental studies [10], but the 
contribution of the pumping rate still may not be com-
pletely ignored. In pilot studies we varied infusion rates 
both for the striatum and cisterna magna infusions, and 
found no clear differences in tracer distribution. Even 
when the infusion rate was reduced to zero, allowing 
only diffusion from the tip of the needle, fluorescein (0.38 
kD) was found to subsequently drain from the striatum 
towards the lateral ventricle. Alternatively, increased per-
fusion rates and/or volumes applied to cisterna magna 
infusion did not appreciably alter the distribution of the 
tracers (data not shown).
Finally, the use of anesthetics in the present study 
might have an effect on the fluid movement. Indeed Xie 
L et  al. showed that during anesthesia the drainage of 
extracellular fluid in mice is increased compared to the 
awake condition, but is similar to the results obtained 
during physiological sleep [17].
Conclusion
The results of our study indicate that tracers injected into 
the striatum find their way to the ventricular system via 
ISF, dominated by bulk flow. The driving force for this 
flow could originate in parenchymal capillaries that act 
as a source of fluid production. In the ventricular system, 
ISF becomes mixed with CSF. Within the ventricles, the 
choroid plexus could play a dual role, not only producing 
CSF but also taking up low molecular weight substances. 
Since tracers injected into the cisterna magna did not 
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enter the ventricular system, our data are consistent with 
the prevailing view that CSF flows along the ventricular 
system, reaches the subarachnoid space via the foramen 
of Magendie, and subsequently enters the subarachnoid 
space in the cisterna magna (Fig. 8) [33]. The relevance of 
this drainage pathway for removal of β-amyloid and other 
waste products remains to be explored.
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